Detalles de la búsqueda
1.
Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.
Med Microbiol Immunol
; 203(1): 47-55, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24062182
2.
Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system.
Clin Exp Vaccine Res
; 12(4): 328-336, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025916
3.
Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice.
Front Immunol
; 14: 1249902, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37869002
4.
The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority.
Front Immunol
; 13: 987984, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36119111
5.
Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination.
Immun Inflamm Dis
; 8(3): 279-291, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32319216
6.
Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
Vaccine
; 37(12): 1630-1637, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765167
7.
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
Front Immunol
; 10: 646, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30984200
8.
Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine.
Biotechnol J
; 13(4): e1700645, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29278302
9.
Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus.
Drug Deliv
; 25(1): 533-545, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29451040
10.
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Front Immunol
; 9: 2312, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356772
11.
Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations.
Vaccines (Basel)
; 5(3)2017 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28792466
12.
Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation.
Vaccines (Basel)
; 5(3)2017 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28749414
13.
A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease.
Antivir Ther
; 11(6): 717-27, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17310816
14.
Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
Eur J Pharm Biopharm
; 93: 231-41, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25896446
15.
Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.
PLoS One
; 10(5): e0125228, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25933037
16.
Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
PLoS One
; 8(7): e69649, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23936066
17.
Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.
PLoS One
; 7(12): e52135, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23284901
18.
The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.
Vaccine
; 26(19): 2314-21, 2008 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-18400343
19.
Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
Int J Cancer
; 118(10): 2529-37, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16353143
20.
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
Vaccine
; 23(10): 1232-41, 2005 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-15652665
Resultados
1 -
20
de 20
1
Próxima >
>>